N-[2-(4-methylphenyl)ethyl]-N'-[2-(5-bromopyridyl)]-thiourea as a potent inhibitor of NNRTI-resistant and multidrug-resistant human immunodeficiency virus type 1

Antiviral Chemistry and Chemotherapy

Volumn 11, Issue 2, 2000, Pages 135-140

  Uckun, Fatih M ^a   Mao, Chen ^a   Pendergrass, Sharon ^a   Maher, Danielle ^a   Zhu, Dan ^a   Tuel Ahlgren, Lisa ^a   Venkatachalam, T K ^a  

^a PARKER HUGHES INSTITUTE   (United States)

Author keywords

Drug resistance; HIV; Reverse transcriptase; Thiourea

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; HI 238; HI 243; HI 244; HI 255; HI 256; HI 275; RNA DIRECTED DNA POLYMERASE INHIBITOR; TROVIRDINE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; DRUG SYNTHESIS; HUMAN IMMUNODEFICIENCY VIRUS 1; MONONUCLEAR CELL; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; VIRUS MUTANT;

EID: 0034012087     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632020001100205     Document Type: Article

References (16)

1. Anonymous (1996) InsightII, computer program. San Diego: Molecular Simulation.
2. Bell FW, Cantrell AS, Hogberg M, Jaskunas SR, Johansson NG, Jordan CL, Kinnick MD, Lind P, Morin JM, Jr, Noreen R, Oberg B, Palkowitz JA, Parrish CA, Pranc P, Sahlberg C, Ternansky RT, Vasileff RT, Vrang L, West SJ, Zhang H & Zhou XX (1995) Phenethylthiazolethiourea (PETT) compounds, a new class of HIV-1 reverse transcriptase inhibitors. 1. Synthesis and basic structure-activity relationship studies of PETT analogs. Journal of Medicinal Chemistry 38:4929-4936.
3. Bohm HJ (1992) LUDI: rule-based automatic design of new substituents for enzyme inhibitor leads. Journal of Computer-Aided Molecular Design 6:593-606.
4. Bohm HJ (1994) The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure. Journal of Computer-Aided Molecular Design 8:243-256.
5. Connolly ML (1983) Solvent-accessible surfaces of proteins and nucleic acids. Science 221:709-713.
6. Das K, Ding J, Hsiou Y, Clark AD Jr, Moereels H, Koymans L, Andries K, Pauwels R, Janssen PA, Boyer PL, Clark P, Smith RH, Jr, Kroeger Smith MB, Michejda CJ, Hughes SH & Arnold E (1996) Crystal structures of S-C1 and 9-C1 TIBO complexed with wild-type HIV-1 RT and 8-C1 TIBO complexed with the Tyr181Cys HIV-1 RT drug-resistant mutant. Journal of Molecular Biology 264:1085-1100.
7. Erice A, Lieler CL, Meyers DE, Sannerund KJ, Irvin JD, Balfour HH & Uckun FM (1993) Inhibition of zidovudine (AZT)-sensitive strains of human immunodeficiency virus type 1 by pokeweed antiviral protein targeted to CD4+ cells. Antimicrobial Agents and Chemotherapy 37:835-838.
8. Larder BA, Kellam P & Kemp SD (1993) Convergent combination therapy can select viable multidrug-resistant HIV-1 in vitro. Nature 365:451-453.
9. Mao C, Sudbeck EA, Venkatachalam TK & Uckun FM (1999) Rational design of N-[2-(2,5-dimethoxyphenylethyl)]-N′-[2-(5-bromopyridyl)]-thiourea (HI-236) as a potent non-nucleoside inhibitor of drug-resistant human immunodeficiency virus. Bioorganic and Medicinal Chemistry Letters 9:1593-1598.
10. Mao C, Vig R, Venkatachalam TK, Sudbeck EA & Uckun FM (1998) Structure-based design of N-[2-(1-piperidinylethyl)-N′-[2-(5-bromopyridyl)]-thiourea and N-[2-(1-piperazinylethyl)-N′-[2-(5-bromopyridyl)]-thiourea as potent non-nucleoside inhibitors of HIV-1 reverse transcriptase. Bioorganic and Medicinal Chemistry Letters 8:2213-2218.
11. Miles SA (1997) HIV infection and AIDS: new biology, therapeutic advances, and clinical implications. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 16 (Suppl. 1):S1-S2.
12. Richman D, Shih CK, Lowy I, Rose J, Prodanovic P, Goff S & Griffin J (1991) Human immunoceficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture. Proceedings of the National Academy of Sciences of the USA 88:11241-11245.
13. Sudbeck EA, Mao C, Vig R, Venkarachalam TK, Tuel-Ahlgren L & Uckun FM (1998) Structure-based design of novel dihydroalkoxybenzyloxopyrimidine (DABO) derivatives as potent non-nucleoside inhibitors of HIV reverse transcriptase. Antimicrobial Agents and Chemotherapy 3225-3233.
14. Uckun FM, Chelstrom LM, Tuel-Ahlgren L, Dibirdik I, Irvin JD, Chandan-Langlie M & Myers DE (1998) TXU (anti-CD7)-pokeweed antiviral protein as a potent inhibitor of human immunodeficiency virus. Antimicrobial Agents and Chemotherapy 42:383-388.
15. Vig R, Mao C, Venkatachalam TK, Tuel-Ahlgren L, Sudbeck EA & Uckun FM (1998) Rational design and synthesis of phenethyl-5-bromopyridyl thiourea derivatives as potent non-nucleoside inhibitors of HIV reverse transcriptase. Bioorganic and Medicinal Chemistry Letters 6:1789-1797.
16. Zarling JM, Moran PA, Haffar O, Sias J, Richman DD, Spina CA, Myers DE, Kuebelbeck V, Ledbetter JA & Uckun FM (1990) Inhibition of HIV replication by pokeweed antiviral protein targeted to CD4+ cells by monoclonal antibodies. Nature 347:92-95.